A targeted door-to-door strategy for sleeping sickness detection in low-prevalence settings in Côte d’Ivoire

Open Access

Table 1.

Results of medical surveys in the Bonon focus from 2000 to 2012.

Strategy and year	Total population surveyed	NSERO	Seroprevalence (%)	NHAT	Prevalence (%)
^*AMS 2000	15,289	170	1.11	74	0.48
^*AMS2002	8284	96	1.16	33	0.4
^*AMS2003	1369	25	1.83	2	0.15
AMS2004	6289	40	0.64	14	0.22
AMS 2007	6738	29	0.43	3	0.04
AMS 2008	3276	17	0.52	1	0.03
AMS 2009	4537	28	0.62	2	0.04
AMS 2012	3919	10 (5TL+)	0.25 (0.12)^†	0	0^††
TDD 2012	1058	10 (7TL+)	0.94 (0.66)^†	4	0.4^††

^†

χ² = 9.87, p = 0.001.

^††

Fisher’s exact test, p = 0.001.

Data already published in [11].

AMS: Active mass screening, TDD: Targeted door-to-door, NSERO: New HAT seropositive individuals, NHAT: New HAT cases, TL+: Positive to the immune trypanolysis test.

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.